Amongst the various types of cancer, breast cancer is a highly heterogeneous disease and
known as the leading cause of death among women globally. The extensive interdisciplinary …

Breast cancer is a leading death cause in women globally. Since therapeutic products do
not yet approach the tumor tissue at adequate levels; therefore, nanoparticle-based …

Docetaxel is widely used in the treatment of metastatic breast cancer. However, its
effectiveness is limited due to chemoresistance and its undesirable side effects. The …

In the present study, luteolin (LTN)-encapsulated chitosan (CS) coated nanostructured lipid
carriers (NLCs) were formulated using the melt emulsification ultrasonication technique …

Over the past decade, there have been remarkable advances in understanding the signaling
pathways involved in cancer development. It is well-established that cancer is caused by the …

Breast cancer has become one of the most common dreadful diseases that target women
across the globe. The most obvious reasons we associate with it are either genetic …

Today, cancer is one of the main health‐related challenges, and in the meantime, breast
cancer (BC) is one of the most common cancers among women, with an alarming number of …

Although the frequency of bone metastases from breast cancer has increased, effective
treatment is lacking, prompting the development of nanomedicine, which involves the use of …

In the present study nanostructured lipid carrier with a combination of Metformin (MET) and
Thymoquinone (THY) was developed, characterized, and was further evaluated for cytotoxic …

The present research was aimed to develop luteolin (LL) loaded pegylated bilosomes (PG-
BLs) for oral delivery. The luteolin bilosomes (BLs) were prepared by the thin-film hydration …